| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021463 Antibodies to ip-10 for treating bone diseases with bone destruction |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | US20100021459 Polypeptide constructs for intracellular delivery |
| 01/28/2010 | US20100021456 Drug for inhibiting,preventing or treatment of rheumatoid arthritis |
| 01/28/2010 | US20100021439 Methods and compositions for treating intervertebral disc degeneration |
| 01/28/2010 | CA2732228A1 Methods and compositions for treating and preventing autoimmune diseases |
| 01/28/2010 | CA2731789A1 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 01/28/2010 | CA2730762A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | CA2730757A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | CA2730499A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/28/2010 | CA2729998A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/27/2010 | EP2147671A1 The composition comprising l-carnitine or derivatives thereof and its use |
| 01/27/2010 | EP2146991A2 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/27/2010 | EP2146974A1 N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same |
| 01/27/2010 | EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor |
| 01/27/2010 | EP1234875B1 Novel metalloprotease having aggrecanase activity |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN100584816C Kutkin derivative, preparation method and application thereof |
| 01/27/2010 | CN100584369C Composition of Chinese traditional medicine for treating rheumatism |
| 01/27/2010 | CN100584368C Medicine for treating rheumatoid and rheumatoid arthritis and its preparation method |
| 01/27/2010 | CN100584367C Medicine composition for treating fracture and its preparation method |
| 01/27/2010 | CN100584343C Medicine health-care usage of globefish I collagen extraction and preparing process thereof |
| 01/27/2010 | CN100584335C Composition and uses for treatment of reactive arthritis or bursitis |
| 01/27/2010 | CN100584320C Chinese traditional medicine for treating rheumatoid disease and osteoarthritis and preparation method |
| 01/27/2010 | CN100584249C Multifunctional cervical vertebra rehabilitation health care pillow with adjustable neck pillow height |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652051 3-amino-benzo[1,2,4]triazine-7-ol-1-oxide; 4-[3-(4-chloro-phenylamino)-benzo[1,2,4]triazin-7-yloxy]-pyridine-2-carboxylic acid methylamide trifluoroacetate salt; modulation of the MAPK pathway; cancer |
| 01/26/2010 | US7652045 Activator of peroxisome proliferator-activated receptor δ |
| 01/26/2010 | US7652038 Methods of reducing angiogenesis |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652019 5,6-trimethylenepyrimidin-4-one compounds |
| 01/26/2010 | US7651678 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2350031C N-arylsulfonylamino acid omega-amides |
| 01/26/2010 | CA2309907C Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells |
| 01/21/2010 | WO2010009474A1 Compositions and methods for treating osteoarthritis |
| 01/21/2010 | WO2010009183A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | WO2010009129A2 Methods of treating autoimmune diseases using cd4 antibodies |
| 01/21/2010 | WO2010009111A2 A drug depot implantable within a synovial joint |
| 01/21/2010 | WO2010009069A1 Chromene modulators of chemokine receptor activity |
| 01/21/2010 | WO2010009068A2 Cyclohexenyl modulators of chemokine receptor activity |
| 01/21/2010 | WO2010008976A2 Combined calcium, magnesium and vitamin d supplements |
| 01/21/2010 | WO2010008761A1 Piperidyl acrylamide antogonists of ccr2 |
| 01/21/2010 | WO2010008733A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/21/2010 | WO2010008619A2 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 01/21/2010 | WO2010008263A1 Use of thalidomide to inhibit the osteoclast-activation process associated with multiple myeloma disease |
| 01/21/2010 | WO2010008023A1 Bone elongation promoter |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007631A1 New composition for treating autoimmune disorders |
| 01/21/2010 | WO2010007427A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2010007168A2 Treatment of rheumatoid arthritis with mammal beta defensins |
| 01/21/2010 | WO2010007082A1 Compositions and methods of use for therapeutic antibodies |
| 01/21/2010 | WO2010006947A1 Novel phenyl-imidazopyridines and pyridazines |
| 01/21/2010 | WO2009146033A3 Compositions and methods for modulating smn activity |
| 01/21/2010 | WO2009134967A3 Use of nucleic acids with reduced pressure therapy for treating wounds |
| 01/21/2010 | WO2009134383A3 Vinyl substituted fatty acids |
| 01/21/2010 | WO2009130005A3 Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides |
| 01/21/2010 | WO2009129433A3 Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
| 01/21/2010 | US20100016783 Non-invasive systems and methods for in-situ photobiomodulation |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016440 Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 01/21/2010 | US20100016391 Isoxazoline Compounds Having MIF Antagonist Activity |
| 01/21/2010 | US20100016365 Substituted 4-amino-piperidines |
| 01/21/2010 | US20100016357 Use of Beta-Aminoalcohols for the Treatment of Inflammatory Disorders and Pain |
| 01/21/2010 | US20100016354 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity |
| 01/21/2010 | US20100016345 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 01/21/2010 | US20100016344 Amino heterocyclic linked pyrimidine derivatives |
| 01/21/2010 | US20100016290 Amorphous polymorph of bazedoxifene acetate |
| 01/21/2010 | US20100016280 Low Dosage Serotonin 5-HT2A Receptor Agonist To Suppress Inflammation |
| 01/21/2010 | US20100016278 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 01/21/2010 | US20100016274 Beta-lactam cannabinoid receptor modulators |
| 01/21/2010 | US20100016257 Method of treatment for osteoarthritis by local intra-articular injection of microparticles |
| 01/21/2010 | US20100016236 Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same |
| 01/21/2010 | US20100016232 Treatment Of Inflammatory Diseases With Mammal Beta Defensins |
| 01/21/2010 | US20100016223 Treatment of cartilage disorders with fgf-18 |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015246 Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
| 01/21/2010 | US20100015230 Bone Morphogenetic Protein Compositions |
| 01/21/2010 | US20100015202 Cancellous construct with support ring for repair of osteochondral defects |
| 01/21/2010 | US20100015197 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 01/21/2010 | US20100015162 treating interleukin-22 (IL-22)-associated disorder such as arthritis or psoriasis by administering the antibody in an amount sufficient to inhibit or reduce immune cell activity in the subject |
| 01/21/2010 | US20100015144 Methods for dosing an activin-actriia antagonist and monitoring of treated patients |
| 01/21/2010 | US20100015126 Methods of Binding of Cross-Beta Structures By Chaperones |
| 01/21/2010 | US20100015102 Composition for treatment of cartilage disease |
| 01/21/2010 | US20100015085 Phase 2 inducers and related signaling pathways protect cartilage against inflammation/infection, apoptosis and stress |
| 01/21/2010 | US20100015068 Methods and Compositions For Altering Biological Surfaces |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2731201A1 New chito-oligomer composition for medical use |
| 01/21/2010 | CA2731067A1 Compositions and methods for treating osteoarthritis |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730929A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | CA2730674A1 Treatment of inflammatory diseases with mammal beta defensins |
| 01/21/2010 | CA2730666A1 Treatment of rheumatoid arthritis with mammal beta defensins |